First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in Advanced NSCLC With 1% or Greater Tumor PD-L1 Expression: Patient-Reported Outcomes From CheckMate 227 Part 1
Resource Type
Article
Authors
Reck, Martin ; Ciuleanu, Tudor-Eliade ; Lee, Jong-Seok ; Schenker, Michael ; Audigier-Valette, Clarisse ; Zurawski, Bogdan ; Linardou, Helena ; Otterson, Gregory A. ; Salman, Pamela ; Nishio, Makoto ; de la Mora Jimenez, Emmanuel ; Lesniewski-Kmak, Krysztof ; Albert, István ; Ahmed, Samreen ; Syrigos, Konstantinos ; Penrod, John R. ; Yuan, Yong ; Blum, Steven I. ; Nathan, Faith E. ; Sun, Xiaowu ; Moreno-Koehler, Alejandro ; Taylor, Fiona ; O'Byrne, Kenneth John
Source
In Journal of Thoracic Oncology April 2021 16(4):665-676
Subject
Language
ISSN
1556-0864